News Summary

Femtech Canada, a national network focused on women’s health innovation, has launched the Women’s Health Medical Pathway (wHealth MedPath) program to support Canadian femtech startups in accelerating commercialization and scaling impact. The initiative, established in partnership with Innovation Factory and supported by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), provides expert-driven support to help startups bring their innovations to market. Through collaborations with physician networks and contract organizations, the program offers services to validate women’s health innovations, reduce risk, increase clinical credibility, and strengthen commercialization strategies. This program aims to position Canada as a global leader in the femtech sector, which has the potential to contribute $27 billion to Canada’s GDP by 2040. Since its launch in 2024, Femtech Canada has built a large ecosystem with over 170 companies, creating jobs and generating significant investment.